OBSIDIAN THERAPEUTICS, INC.

Profile

Company Names

OBSIDIAN THERAPEUTICS, INC.

Addresses

1030 MASSACHUSETTS AVENUE, SUITE 400, CAMBRIDGE, MA 02138

Phone Numbers

339-364-6721

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$32,436,323.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2017-11-29 
$32,436,323.00 
$49,936,323.00 
$17,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER 
 
BARRETT 
EXECUTIVE OFFICER, DIRECTOR
VITAE PHARMACEUTICALS, INC   |  HELICOS BIOSCIENCES CORP   |  SIRION HOLDINGS, INC.   |  ZAFGEN, INC.   |  MOLECULAR BIOMETRICS INC   |  STROMEDIX INC   |  INFACARE PHARMACEUTICAL CORP   |  JENAVALVE TECHNOLOGY INC   |  MNEMOSYNE PHARMACEUTICALS INC   |  SYNLOGIC, INC.   |  PLAYGROUND VENTURES, L.P.   |  PLAYGROUND GLOBAL, LLC   |  SUBPAC, INC.   |  SYNLOGIC, LLC   |  INDALO THERAPEUTICS, INC.   |  BINGHAM NATURAL WINES, LLC   |  OBSIDIAN THERAPEUTICS, INC.   |  SYNLOGIC, INC.   |  LARIMAR THERAPEUTICS, INC.   |  PLAYGROUND COMPUTE, L.P.   |  ARTIFICIAL, INC.   |  ANJUNA SECURITY, INC.   |  MOSAIC ML, INC.   |  PERKINELMER INC   |  PLAYGROUND ACQUIRE, L.P.   |  PLAYGROUND OMEGA, L.P.   |  PLAYGROUND HELIX, L.P.   |  PSIQUANTUM, CORP.   |  PLAYGROUND OMEGA 2, L.P.   |  XLIGHT INC.   |  PLAYGROUND GENESIS, L.P.   |  PLAYGROUND VENTURES IV, L.P.   |  PLAYGROUND VENTURES AFFILIATES IV, L.P.
JASON 
 
GARDNER 
DIRECTOR
WEBVISIBLE INC   |  MARQETA, INC.   |  KAREO INC   |  MAGENTA THERAPEUTICS, INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  PATIENTPOP, INC.
MICHAEL 
 
GILMAN 
EXECUTIVE OFFICER, DIRECTOR
GENE NETWORK SCIENCES, INC.   |  STROMEDIX INC   |  X4 PHARMACEUTICALS, INC.   |  SCHOLAR ROCK LLC   |  ARRAKIS THERAPEUTICS, INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  SCHOLAR ROCK HOLDING CORP   |  2660 INGALLS ST, LLC   |  GREEN HILLS REAL ESTATE, LLC   |  KILLINGTON VALLEY HOLDINGS, LLC   |  KAUS PR REIT, LLC   |  6980 STUART ST, LLC   |  KP PRISM REIT, LLC
KAREN 
 
HONG 
DIRECTOR
AGILE THERAPEUTICS INC   |  MERSANA THERAPEUTICS INC   |  PALLEON PHARMACEUTICALS INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  CYTEIR THERAPEUTICS, INC.   |  STRIDEBIO, INC.
DAVID 
 
NEAFUS 
EXECUTIVE OFFICER
SUSTAINX INC   |  AFFERENT PHARMACEUTICALS, INC.   |  PANGENX, INC.   |  MICROCHIPS BIOTECH, INC.   |  SYNDEVRX INC   |  ARRAKIS THERAPEUTICS, INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  NAYAN THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  KERA THERAPEUTICS, INC.   |  SIGHTSTREAM BIOTHERAPEUTICS, INC.
CAROLYN 
 
NG 
DIRECTOR
OBSIDIAN THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  NUVAIRA, INC.   |  ODYSSEY THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-12-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#